Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 November 2022 | Story Jóhann Thormählen | Photo Jóhann Thormählen
Mating Monokoane Louzanne Coetzee Claus Kempen
Louzanne Coetzee, Claus Kempen – who both run for the Kovsie Athletics club – and Mating Monokoane, the University of the Free State (UFS) women’s soccer captain, are joining hands by starting the Louzanne Coetzee Foundation. Here, from the left, are Monokoane, Coetzee, and Kempen at Pellies Park on the UFS Bloemfontein Campus.

Leaving a legacy. Although she is still in the prime of her career, this has motivated Louzanne Coetzee to start a foundation to benefit others.

The sports star, who won silver (1 500 m; T11) and bronze (marathon; T12) medals at the Paralympics in Tokyo in 2021, wants to empower and support para-athletes. And she is joining hands with two fellow Kovsies to do it.

They will invest their time and talents towards the Louzanne Coetzee Foundation, a result of an idea that started while the 29-year-old Coetzee was competing at the Paralympic Games.

The University of the Free State (UFS) Residence Head of Akasia started the foundation in partnership with Claus Kempen, her guide, and Mating Monokoane, the UFS women’s soccer captain.

“I realised there was a gap in development, especially for para-athletes,” she says.

“You get to a certain level, and in South Africa there is uncertainty with regard to funding and educating athletes.”

 

Identifying needs

According to Kempen, the foundation will start by generating funds to assist others. Help can be provided by educating, informing or “physically giving financial aid to someone in need, whether it is a wheelchair, entering for a competition, or a bursary”.

Coetzee serves in many leadership roles, such as the South African Sports Confederation and Olympic Committee (SASCOC) Athletes Commission and says she will make use of these.

“I am involved in the South African Sports Association for the Physically Disabled, and that gives me a good platform to see where help is needed.

“And with Mating involved in the UFS, it gives us good insights into where the needs are.”

Coetzee will also work with organisations such as the Free State Sport Association for the Physically Disabled and Visually Impaired. “I am also going to start getting more involved with KovsieSport. It is very exciting.”

 

Guiding and following

Coetzee and Kempen have been talking about a foundation for some time and she wanted to include Monokoane, the 2022 Prime of Akasia.

They have been working together for the past three years. Coetzee admires her passion, ethics, and “knows she also has a heart for leaving a legacy”.

And it is fitting that their residence motto is: ‘Live, love, learn and leave a legacy’.

Kempen says it is a privilege to be involved.

“Normally my role is to guide Louzanne, but in this instance I am following, and she is taking me on a journey to explore what we can do to empower other individuals and groups.”

He congratulated the UFS on a successful leadership pathway.

“It is something we like to talk about, namely developing students into leaders.”

“Louzanne took the opportunity with Mating, and they went from a student and employee relationship to partners.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept